Global Point-of-Care Glucose Testing Industry Outlook 2025-2029: Market Set to Cross $6.5 Billion Milestone

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Point-of-Care Glucose Testing Market Size By 2025?
The scope of the glucose testing sector at the point of care has witnessed consistent expansion lately, projected to advance from a valuation of $4.91 billion in 2024 to $5.14 billion in 2025; this progression reflects a compound annual growth rate (CAGR) of 4.7%, with the momentum during the past period stemming from several factors, including the rising incidence of diabetes, heightened recognition regarding diabetes control, the swelling elderly demographic, improvements in healthcare facilities, and the broader integration of point-of-care diagnostic methods.

How Big Is the Point-of-Care Glucose Testing Market Size Expected to Grow by 2029?
Anticipating robust expansion, the market centered on glucose testing conducted at the point of care is projected to achieve a valuation of $6.5 billion by the year 2029, reflecting a compound annual growth rate of 6.0% throughout the upcoming period. This forecasted upswing is fundamentally driven by several key factors, including the burgeoning use of telemedicine, mounting focus on tailoring diabetes treatment to the individual, proliferation of dedicated diabetes management initiatives, heightened financial commitment to glucose testing research and development efforts, and the wider acceptance of continuous glucose monitoring systems. Furthermore, significant prevailing trends shaping this sector involve the innovation of glucose monitoring tools capable of being worn, the incorporation of mobile device connectivity into testing procedures, the increasing use of point-of-care diagnostics within home care environments, the implementation of artificial intelligence for interpreting glucose data, and the broader deployment of remote monitoring solutions for diabetic patients.

View the full report here:
https://www.thebusinessresearchcompany.com/report/point-of-care-glucose-testing-global-market-report

Which Key Market Drivers Powering Point-of-Care Glucose Testing Market Expansion and Growth?
The escalating incidence of diabetes is projected to act as a significant catalyst for expansion within the point-of-care glucose testing sector in the near future. As a long-term metabolic condition characterized by elevated blood sugar, diabetes progressively inflicts serious harm upon vital organs, including the cardiovascular system, vasculature, vision apparatus, renal system, and nervous system. The technology known as point-of-care glucose testing proves invaluable, often employed for assessing glucose concentrations among inpatients to enable rapid therapeutic adjustments contingent on glycemic fluctuations, thereby optimizing treatment efficacy and bolstering overall diabetes care. To illustrate this trend, data released in June 2024 by The National Health Service (NHS England), the public healthcare provider in the UK, revealed that the count of individuals diagnosed with pre-diabetes within England climbed to 3,615,330 in 2023, representing an 18 percent jump from the 3,065,825 recorded in 2022; furthermore, for the demographic under the age of forty, reported instances saw an even sharper rise of almost 25 percent, moving from 173,166 in 2022 to 216,440 the following year. Consequently, this expanding diabetic patient base directly fuels the market growth for point-of-care glucose testing solutions.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12207&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Point-of-Care Glucose Testing Market?
A paramount movement within the sphere of point-of-care glucose testing involves a significant emphasis on groundbreaking product development, with leading market participants channeling efforts into creating novel solutions to solidify their competitive standing. Reflecting this, in January of 2022, the Swiss medical technology firm F. Hoffmann-La Roche AG launched Cobas Pulse, a fresh monitor designed for healthcare professionals to measure blood glucose at the point of care. This instrument is designed to integrate seamlessly with a complementary mobile accessory resembling a smartphone equipped with a touchscreen interface to host its specific applications. The Cobas Pulse itself is a portable unit incorporating functionalities such as automated test strip reading, an integrated camera, and a touchscreen interface facilitating the recording of diagnostic information; furthermore, its durable casing allows for easy disinfection, making it suitable for diverse patient demographics ranging from neonates to those in intensive care settings. Beyond core testing capabilities, the device aims to streamline clinical operations by hosting sophisticated tools like the Glucommander dosing software directly on the glucose reader, augmented by the availability of decision-support applications for download from collaborators including Smart4Diagnostics, CardioSignal, and SteadySense.

What Are the Emerging Segments in the Point-of-Care Glucose Testing Market?
The point-of-care glucose testingmarket covered in this report is segmented -

1) By Product: Lancet And Lancing Devices; Strips; Meters
2) By Testing Site: Fingertips; Alternate Site Testing
3) By Applications: Type-1 Diabetes; Type-2 Diabetes
4) By End-User: Professional Diagnostic Centers; Hospitals And Clinics; Home Care Settings; Other End Users

Subsegments:
1) By Lancet And Lancing Devices: Single-Use Lancets; Multi-Use Lancets; Adjustable Lancing Devices
2) By Strips: Glucose Test Strips; ket*one Test Strips; Combo Strips (Glucose And ket*one)
3) By Meters: Blood Glucose Meters; Continuous Glucose Monitoring (CGM) Meters; Bluetooth-Enabled Meters

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12207&type=smp

Who Are the Global Leaders in the Point-of-Care Glucose Testing Market?
Major companies operating in the point-of-care glucose testing market include F Hoffmann-La Roche Ltd., Abbott Laboratories Inc., Danaher Corporation, Siemens Healthineers, Becton, dic*kinson and Company, TaiDoc Technology Corporation, B. Braun Melsungen AG, Beckman Coulter Inc., Nipro Corporation, Dexcom Inc., Bio-Rad Laboratories Inc., LifeScan Inc., Nova Biomedical Corporation, Ypsomed AG, Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Radiometer Medical ApS, HemoCue AB, EKF Diagnostics Holdings plc, Trinity Biotech plc, Bionime Corporation, PTS Diagnostics, ForaCare Inc., Menarini Diagnostics, ACON Laboratories Inc., Senseonics Holdings Inc., Prodigy Diabetes Care LLC, Nemaura Medical Inc.

Which are the Top Profitable Regional Markets for the Point-of-Care Glucose Testing Industry?
North America was the largest region in the point-of-care glucose testing market in 2024. The regions covered in the point-of-care glucose testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12207

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.